L-004-2019

Agreement ID
L-004-2019
Lead IC
NIBIB
Exclusivity
Exclusive
External Party
Sinotau Pharmaceutical Group
Fiscal Year
2019
Territory
Worldwide
Execution Date
Effective Date
Export Date
Technologies
TAB-4579     Evans Blue Modified Small Molecule-based Prostate-specific Membrane Antigen (PSMA) Radiotherapy and Nuclear Imaging